Prevalence of Complications and Clinical Audit of Management of Type 2 Diabetes Mellitus: A Prospective Hospital Based Study

Kulshrestha, Mukul; Seth, Seema; Tripathi, Ashutosh; Seth, Anindita; Kumar, Anoop

doi:10.7860/jcdr/2015/15369.6848

Cited by 10 publications

(12 citation statements)

References 16 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Several studies have implied that besides the 3B control rate, many other factors also contribute to microvascular and macrovascular morbidity, including age, duration of diabetes and weight [28][29][30] . Earlier exposure to hyperglycemia could lead to higher microvascular and macrovascular morbidity [31][32][33] .…”

Section: Discussionmentioning

confidence: 99%

Greater macrovascular and microvascular morbidity from type 2 diabetes in northern compared with southern China: A cross‐sectional study

Wang

Xing

et al. 2020

J of Diabetes Invest

View full text Add to dashboard Cite

Aims/Introduction There are substantial differences in genes, diet, culture and environment between the northern and southern Chinese populations, which might influence treatment strategy and screening policy. We studied the differences in type 2 diabetes and diabetic complications between northern and southern China. Materials and Methods We carried out a cross‐sectional survey using data from the China Cardiometabolic Registries on blood pressure, blood lipids and blood glucose in 25,398 Chinese type 2 diabetes patients. Macrovascular, microvascular and other complications were collected by self‐report or medical records, and then divided into the northern and southern groups by the boundary of the Yangtze River. Results Northern patients were younger, and had heavier weight, greater body mass index and waist circumference, higher blood pressure, higher total cholesterol, higher low‐density lipoprotein cholesterol, and higher hemoglobin A1C. The prevalence of cardiovascular, cerebrovascular and macrovascular complications were 1.76‐fold, 1.24‐fold and 1.47‐fold more in northern than that in southern Chinese patients. In addition, the prevalence of diabetic nephropathy, retinopathy, neuropathy and microvascular complications in northern Chinese patients also increased. When stratified by age, the difference in both cardiovascular disease and ischemic stroke morbidity became significant, even in the 35–44 years age group. Conclusions More macrovascular and microvascular complications were found in northern compared with southern patients, and the largest difference also appeared in the younger age groups <55 years, which might be meaningful to a screening and treatment strategy according to geographic differences.

show abstract

Section: Discussionmentioning

confidence: 99%

Greater macrovascular and microvascular morbidity from type 2 diabetes in northern compared with southern China: A cross‐sectional study

Wang

Xing

et al. 2020

J of Diabetes Invest

View full text Add to dashboard Cite

show abstract

“…Autori su klasifikovali pacijente u grupe bez komplikacija i sa komplikacijama, a zatim na osnovu vrednosti HbA 1c na one koji su postigli adekvatnu (<7%), zadovoljavajuću (7-8%) i neadekvatnu (>8%) metaboličku kontrolu. Utvrdili su da je najveći broj pacijenata sa gangrenom donjih ekstremiteta imao vrednosti HbA 1c >8% (8). U našoj studiji pacijenti lečeni hirurškim putem imali su statistički značajno više vrednosti HbA 1c u poređenju sa pacijentima koji su lečeni konzervativnim pristupom (Tabela II).…”

Section: Diskusijaunclassified

“…U pomenutoj studiji stopa preživljavanja pacijenata u prve tri godine nakon amputacije iznosila je 50% (7). Slični rezultati su dobijeni i u nedavno publikovanoj studiji koja je pratila razvoj komplikacija kod pacijenata sa tipom 2 DM tokom 11 meseci (8).…”

Section: Diskusijaunclassified

Significance of glycosylated haemoglobin determination for the assessment of lower-extremity amputation risk in patients with diabetic foot

Stefanović¹,

Bosić²,

Vekić³

et al. 2019

Arhiv za farmaciju

View full text Add to dashboard Cite

Kratak sadržajGlikohemoglobin (HbA 1c ) je važan parametar za praćenje dugoročne metaboličke kontrole i procenu rizika za razvoj hroničnih komplikacija kod pacijenata sa dijabetes melitusom (DM). U ovoj studiji ispitivali smo povezanost postignute metaboličke kontrole u tipu 2 DM sa rizikom za razvoj i primenjenim modalitetom lečenja sindroma dijabetesnog stopala (SDS). U istraživanju je učestvovalo 111 pacijenata (80 muškaraca i 31 žena) sa tipom 2 DM, starosti 65,5 ± 9,8 godina. Kod 41 pacijenta SDS je lečen neoperativnim (konzervativnim) pristupom, hirurška intervencija manjeg obima (amputacija u predelu stopala) je izvršena kod 41, a opsežna hirurška intervencija (amputacija u predelu potkolenice) kod 29 pacijenata. Koncentracije biohemijskih parametara i HbA 1c su određene standardnim laboratorijskim metodama. U ispitivanoj grupi najučestaliji faktor rizika za nastanak SDS (82% pacijenata) bila je neadekvatna glikoregulacija (HbA 1c >8%). Utvrdili smo da su pacijenti koji su lečeni hirurškim putem imali statistički značajno više vrednosti HbA 1c u poređenju sa pacijentima koji su lečeni neoperativnim pristupom (P<0,05). Ukupan broj pacijenata koji je podvrgnut hirurškom lečenju bio je značajno veći u grupi sa neadekvatnom glikoregulacijom (68,2% pacijenata sa neadekvatnom vs. 40% pacijenata sa adekvatnom glikoregulacijom; P<0,05). Utvrdili smo da je verovatnoća za amputaciju 3,2 puta veća ukoliko pacijent ima neadekvatnu glikoregulaciju (OR=3,21; 95%CI:1,69; P<0,05). Naši rezultati su pokazali da se održavanjem dobre metaboličke kontrole u tipu 2 DM smanjuje rizik za razvoj SDS, ali i stepen invazivnosti postupka lečenja SDS.Ključne reči: dijabetes melitus; metabolička kontrola; hronične komplikacije; HbA 1c .

show abstract

“…Most commonly seen diabetes complications are retinopathy with a potential loss of vision, nephropathy that can result in renal failure, peripheral neuropathy leading to foot ulcers, Charcot foot and amputation, autonomic neuropathy that can causes gastrointestinal, genitourinary, and cardiovascular symptoms. The patients with a chronically elevated glucose level have high incidence of atherosclerotic vascular changes, which cause development of peripheral arterial disease, cerebrovascular, and cardiovascular complications [6,7]. Number of complications can be reduced, if patients maintain good glycemic control.…”

Section: Diabetes Mellitusmentioning

confidence: 99%

Empowering Diabetes Patient with Mobile Health Technologies

Krošel¹,

Švegl²,

Vidmar³

et al. 2016

Mobile Health Technologies - Theories and Applications

View full text Add to dashboard Cite

Chronic diseases, especially diabetes mellitus, are huge public health burden. Therefore, new health care models for sharing the responsibility for care among health care providers and patients themselves are needed. The concept of empowerment promotes patient's active involvement and control over their own health. It can be achieved through education, self-management, and shared decision making. "ll these aspects can be covered by mobile health technologies, the so-called mHealth. This term comprises mobile phones, patient monitoring devices, tablets, personal digital assistants, other wireless devices, and numerous apps. Many challenges of diabetics can be addressed by mHealth, including glycemic control, nutrition control, physical activity, high blood pressure, medication adherence, obesity, education, diabetic retinopathy screening, diabetic foot screening, and psychosocial care. However, mHealth plays only minor role in diabetes management, despite numerous apps on the market. Namely, these apps have many shortcomings and the majority of them does not include important functions. Moreover, these apps lack the perceived additional benefit by the user and the ease of use, important factors for acceptance of mHealth. Studies of diabetes apps regarding usability and accessibility have shown moderate results. "eside improvements of apps usability, the future of diabetes mHealth lies probably in personalized education and self-management with the help of decision support systems. "t the same time, work on artificial pancreas is in progress and smartphone could be used as user interface.

show abstract

Prevalence of Complications and Clinical Audit of Management of Type 2 Diabetes Mellitus: A Prospective Hospital Based Study

Cited by 10 publications

References 16 publications

Greater macrovascular and microvascular morbidity from type 2 diabetes in northern compared with southern China: A cross‐sectional study

Greater macrovascular and microvascular morbidity from type 2 diabetes in northern compared with southern China: A cross‐sectional study

Significance of glycosylated haemoglobin determination for the assessment of lower-extremity amputation risk in patients with diabetic foot

Empowering Diabetes Patient with Mobile Health Technologies

Contact Info

Product

Resources

About